HCA Healthcare (NYSE:HCA) has appointed John W. Chidsey, III as an independent director, enhancing its board's expertise and corporate governance. Meanwhile, the company's inclusion in multiple Russell 1000 indexes underscores its stability and appeal to defensive investors. During the quarter, HCA also emphasized shareholder value through its share repurchase activities. Overall, the company's share price rose 13% in line with broader market gains over the past year. These strategic moves, coupled with solid financial performance in Q1, including increased sales and net income, have reinforced investor confidence, contributing to a 13% quarterly price move.